LIGAND PHARMACEUTICALS INC - COM NEW (LGND)

Q4 2016 13F Holders as of 12/31/2016

Type / Class
Equity / COM NEW
Number of holders
266
Total Shares
24.8M
Shares change
+7.76K
Total reported value, excl. options
$2.52B
Value change
+$333K
Put/Call ratio
1.44
Number of buys
127
Number of sells
-124
Price
$101.61
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.